Limited visibility
Kidney function is typically assessed through occasional tests, leaving long periods without actionable insight.
Kidney Monitoring, Redefined
Continuous kidney insight for earlier, better decisions
ACCREMeter is developing a patient-centered monitoring approach that brings clinically relevant kidney data closer to real-world care.
Why change is needed
Kidney monitoring still relies on isolated measurements
Delayed response
Changes in kidney function may only become visible once progression has already occurred.
Growing burden
Chronic kidney disease continues to grow globally, requiring more proactive monitoring approaches.
How it works
A clear three-step product experience.
Sample
A guided collection step designed for consistency and practical use in real-world care settings.
Measure
Results are presented in a way that helps patients understand trends and what influences their kidney function.
Act and adjust
Clear insight supports earlier lifestyle adjustments and care decisions that may help slow disease progression.
Our approach
Bringing kidney monitoring closer to real-world care
Scientific foundation
Built on analytical chemistry designed to improve reliability of creatinine measurement.
Clinical relevance
Designed to support real-world care decisions, not only laboratory analysis.
Patient-centered use
Focused on helping patients understand their condition and act earlier.
PATENTED TECHNOLOGY
A patented approach to creatinine measurement
ACCREMeter is built on a patented chemical method designed to improve selectivity in creatinine measurement compared to traditional approaches.
Designed for more reliable measurement in complex biological conditions.
Developed through analytical chemistry and applied medical research.
Adapted for future use in both clinical and patient-centered settings.
Impact
A long-term commitment to better kidney care decisions.
Chronic kidney disease affects over 850 million people worldwide. Our vision is to support earlier understanding, stronger clinical confidence, and better-informed decisions in managing its progression.
Team
A focused team built for scientific depth and operational delivery.
Wiktor 
CEO & Software
Leads product, technology, and execution, with a focus on building scalable deeptech solutions.
Łukasz
Scientific Lead, PhD, Assistant Professor (University of Warsaw)
PhD and Assistant Professor at the University of Warsaw. Leads development of the measurement method and scientific direction of the project.
Anastasija
Operations
Leads operational coordination, supporting execution across research, product, and communication.
Jaroslavs
Business Development
Supports business development, partnerships, and go-to-market activities.
PARTNERS
Built for collaboration across care and research
University of Warsaw
ACCREMeter is University of Warsaw spin-off venture
EIT Health
ACCREMeter was setup as a result of EIT Health DTVB call.
NEWS
Latest updates from ACCREMeter
April 2026
ACCREMeter begins development of KidneyCareHub platform
Work begins on KidneyCareHub.com — a patient-focused platform designed to educate, engage, and support individuals with chronic kidney disease.
Read more
March 2026
ACCREMeter participates in European DeepTech Week in Paris
The team joins leading European innovators in Paris to explore deeptech funding, commercialization, and global scaling opportunities.
Read more
February 2026
ACCREMeter recognized at Startup Founders Stars
The project receives recognition at Startup Founders Stars, highlighting its innovation and impact potential in digital health.
Read more
January 2026
ACCREMeter company officially established and operational
The company is now fully established and ready to execute its development roadmap towards clinical validation and product commercialization.
Read more
December 2025
ACCREMeter wins Warsaw Booster programme
ACCREMeter is recognized as one of the top projects in the Warsaw Booster programme, validating its approach to patient-centered kidney monitoring.
Read more
July 2025
ACCREMeter selected for Warsaw Booster programme
The team joins Warsaw Booster to further develop its business model and prepare for market entry in the healthcare sector.
Read more
February 2025
ACCREMeter selected for EIT Health Deep Tech Venture Builder
The project joins the EIT Health Deep Tech Venture Builder programme to accelerate commercialization and validation of its kidney monitoring technology.
Read moreContact